1. |
World Health Organization. Hepatitis B vaccines. Wkly Epidemiol Rec, 2009, 1263(1): 20-20.
|
2. |
Gust ID. Epidemiology of hepatitis B infection in the Western Pacific and South East Asia. Gut, 1996, 38(Suppl 2): S18-S23.
|
3. |
Kim HR, Cheon SH, Rha SY, et al. Treatment of recurrent hepatocellular carcinoma after liver transplantation. Liver Transplantation, 2011, 7(S2): 258-269.
|
4. |
Roayaie S, Schwartz JD, Sung MW, et al. Recurrence of hepatocellular carcinoma after liver transplant: patterns and prognosis. Liver Transpl, 2004, 10(4): 534-540.
|
5. |
Llovet JM, Bruix J. Llovet JM, et al. Novel advancements in the management of hepatocel-lular carcinoma in 2008. J Hepatol 48 (Suppl 1): S20-S37.
|
6. |
刘清, 罗永胜, 王伟, 等. 凋亡素联合阿霉素与顺铂对肝细胞癌的凋亡作用研究. 广东医学, 2009, 30(7): 1035-1037.
|
7. |
高广猷. 抗癌新药——顺铂简介. 中国新药与临床杂志, 1983, 2(1): 23-27.
|
8. |
蒙志斌, 马亦龙, 康平, 等. KMG 微球与碘油在选择性支气管动脉栓塞治疗中晚期肺癌的疗效分析. 广西医学, 2009, 31(7): 930-933.
|
9. |
张溪, 张博恒. 负载阿霉素的洗脱微球肝动脉化疗栓塞治疗难以手术切除的肝细胞肝癌的疗效和安全性. 中国临床医学, 2013, 20(3): 419-421.
|